These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38386435)

  • 1. Prevalence, Safety, and Metabolic Control Among Danish Children and Adolescents with Type 1 Diabetes Using Open-Source Automated Insulin Delivery Systems.
    Fagerberg AR; Borch L; Kristensen K; Hjelle JS
    Diabetes Technol Ther; 2024 May; 26(5):287-297. PubMed ID: 38386435
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term assessment of the NHS hybrid closed-loop real-world study on glycaemic outcomes, time-in-range, and quality of life in children and young people with type 1 diabetes.
    Ng SM; Wright NP; Yardley D; Campbell F; Randell T; Trevelyan N; Ghatak A; Hindmarsh PC
    BMC Med; 2024 Apr; 22(1):175. PubMed ID: 38659016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-Month Effectiveness of Advanced
    Tornese G; Buzzurro F; Carletti C; Faleschini E; Barbi E
    Front Endocrinol (Lausanne); 2021; 12():766314. PubMed ID: 34858339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycemic Outcomes Persist for up to 2 Years in Very Young Children with the Omnipod
    DeSalvo DJ; Bode BW; Forlenza GP; Laffel LM; Buckingham BA; Criego AB; Schoelwer M; MacLeish SA; Sherr JL; Hansen DW; Ly TT
    Diabetes Technol Ther; 2024 Jun; 26(6):383-393. PubMed ID: 38277156
    [No Abstract]   [Full Text] [Related]  

  • 5. Real-World Use of Do-It-Yourself Artificial Pancreas Systems in Children and Adolescents With Type 1 Diabetes: Online Survey and Analysis of Self-Reported Clinical Outcomes.
    Braune K; O'Donnell S; Cleal B; Lewis D; Tappe A; Willaing I; Hauck B; Raile K
    JMIR Mhealth Uhealth; 2019 Jul; 7(7):e14087. PubMed ID: 31364599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world glycaemic outcomes of automated insulin delivery in type 1 diabetes: A meta-analysis.
    Yang Q; Zeng B; Hao J; Yang Q; Sun F
    Diabetes Obes Metab; 2024 Sep; 26(9):3753-3763. PubMed ID: 38888056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-World Evidence of Off-Label Use of Commercially Automated Insulin Delivery Systems Compared to Multiple Daily Insulin Injections in Pregnancies Complicated by Type 1 Diabetes.
    Quirós C; Herrera Arranz MT; Amigó J; Wägner AM; Beato-Vibora PI; Azriel-Mira S; Climent E; Soldevila B; Barquiel B; Colomo N; Durán-Martínez M; Corcoy R; Codina M; Díaz-Soto G; Márquez Pardo R; Martínez-Brocca MA; Rebollo Román Á; López-Gallardo G; Cuesta M; García Fernández J; Goya M; Vega Guedes B; Mendoza Mathison LC; Perea V
    Diabetes Technol Ther; 2024 Aug; 26(8):596-606. PubMed ID: 38417014
    [No Abstract]   [Full Text] [Related]  

  • 8. During an 18-month course of automated insulin delivery treatment, children aged 2 to 6 years achieve and maintain a higher time in tight range.
    Pulkkinen MA; Varimo TJ; Hakonen ET; Hero MT; Miettinen PJ; Tuomaala AK
    Diabetes Obes Metab; 2024 Jun; 26(6):2431-2438. PubMed ID: 38514384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the usage of an open-source automated insulin delivery system and the MiniMed™ 780 G system in children and adolescents with type 1 diabetes in real-world settings: the AWeSoMe study group.
    Landau Z; Lebenthal Y; Mazor-Aronovitch K; Brener A; Levek N; Jacobi-Polishook T; Ben Ari T; Abiri S; Haim A; Nir J; Rachmiel M; Pinhas-Hamiel O
    Endocrine; 2024 Jun; 84(3):943-950. PubMed ID: 38225516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-source automated insulin delivery systems (OS-AIDs) in a pediatric population with type 1 diabetes in a real-life setting: the AWeSoMe study group experience.
    Nir J; Rachmiel M; Fraser A; Lebenthal Y; Brener A; Pinhas-Hamiel O; Haim A; Stern E; Levek N; Ben-Ari T; Landau Z
    Endocrine; 2023 Aug; 81(2):262-269. PubMed ID: 37222881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycemic variability through the perspective of the glycemia risk index and time in range and their association with glycated hemoglobin A1c in pediatric patients on sensor-augmented pump therapy.
    Bukara-Radujkovic G; Miljkovic V
    Front Endocrinol (Lausanne); 2024; 15():1388245. PubMed ID: 38957442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of time in tight range (TITR) in evaluating metabolic control in pediatric and adult patients with type 1 diabetes in treatment with advanced hybrid closed-loop systems.
    Bahillo-Curieses P; Fernández Velasco P; Pérez-López P; Vidueira Martínez AM; Nieto de la Marca MO; Díaz-Soto G
    Endocrine; 2024 Nov; 86(2):539-545. PubMed ID: 38814372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-school and school-aged children benefit from the switch from a sensor-augmented pump to an AndroidAPS hybrid closed loop: A retrospective analysis.
    Petruzelkova L; Jiranova P; Soupal J; Kozak M; Plachy L; Neuman V; Pruhova S; Obermannova B; Kolouskova S; Sumnik Z
    Pediatr Diabetes; 2021 Jun; 22(4):594-604. PubMed ID: 33576551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with glycemic control in adult type 1 diabetes patients treated with insulin pump therapy.
    Matejko B; Skupien J; Mrozińska S; Grzanka M; Cyganek K; Kiec-Wilk B; Malecki MT; Klupa T
    Endocrine; 2015 Feb; 48(1):164-9. PubMed ID: 24798448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-World Evidence of Omnipod
    Forlenza GP; DeSalvo DJ; Aleppo G; Wilmot EG; Berget C; Huyett LM; Hadjiyianni I; Méndez JJ; Conroy LR; Ly TT; Sherr JL
    Diabetes Technol Ther; 2024 Aug; 26(8):514-525. PubMed ID: 38375861
    [No Abstract]   [Full Text] [Related]  

  • 16. One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes.
    Petrovski G; Al Khalaf F; Campbell J; Umer F; Almajaly D; Hamdan M; Hussain K
    Acta Diabetol; 2021 Feb; 58(2):207-213. PubMed ID: 33044604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the Impact of Subcutaneous Catheter Change on Glucose Control in Patients with Type 1 Diabetes Treated by Insulin Pump in Open- and Closed-Loop Modes.
    Julla JB; Jacquemier P; Bonnemaison E; Fagherazzi G; Hanaire H; Bellicar Schaepelynck P; Mihaileanu M; Renard E; Reznik Y; Riveline JP
    Diabetes Technol Ther; 2024 Jul; 26(7):442-448. PubMed ID: 38350126
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes.
    Ware J; Allen JM; Boughton CK; Wilinska ME; Hartnell S; Thankamony A; de Beaufort C; Schierloh U; Fröhlich-Reiterer E; Mader JK; Kapellen TM; Rami-Merhar B; Tauschmann M; Nagl K; Hofer SE; Campbell FM; Yong J; Hood KK; Lawton J; Roze S; Sibayan J; Bocchino LE; Kollman C; Hovorka R;
    N Engl J Med; 2022 Jan; 386(3):209-219. PubMed ID: 35045227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent scanning using flash glucose monitoring contributes to better glycemic control in children and adolescents with type 1 diabetes.
    Urakami T; Yoshida K; Kuwabara R; Mine Y; Aoki M; Suzuki J; Morioka I
    J Diabetes Investig; 2022 Jan; 13(1):185-190. PubMed ID: 34143544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.